Joachim B Boers
Overview
Explore the profile of Joachim B Boers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Vliet M, Boers R, Boers J, Schaffers O, van der Meeren L, Steegers-Theunissen R, et al.
Eur J Clin Invest
. 2024 Nov;
55(3):e14363.
PMID: 39589853
Background: Placental-originated cell-free DNA (cfDNA) provides unique opportunities to study (epi)genetic placental programming remotely, but studies investigating the cfDNA methylome are scarce and usually technologically challenging. Methylated DNA sequencing (MeD-seq)...
2.
van Bever Y, Boers R, Bruggenwirth H, van IJcken W, Magielsen F, de Klein A, et al.
Epigenetics
. 2024 Aug;
19(1):2392048.
PMID: 39151125
In patients with proximal hypospadias, often no genetic cause is identified despite extensive genetic testing. Many genes involved in sex development encode transcription factors with strict timing and dosing of...
3.
Giannini L, Boers R, van der Ende E, Poos J, Jiskoot L, Boers J, et al.
Ann Clin Transl Neurol
. 2024 Mar;
11(3):744-756.
PMID: 38481040
Objective: Methylation of plasma cell-free DNA (cfDNA) has potential as a marker of brain damage in neurodegenerative diseases such as frontotemporal dementia (FTD). Here, we study methylation of cfDNA in...
4.
Fu S, Deger T, Boers R, Boers J, Doukas M, Gribnau J, et al.
Cancers (Basel)
. 2023 Oct;
15(19).
PMID: 37835478
Aberrant DNA methylation changes have been reported to be associated with carcinogenesis in cirrhotic HCC, but DNA methylation patterns for these non-cirrhotic HCC cases were not examined. Therefore, we sought...
5.
Eikenboom E, Wilting S, Deger T, Srebniak M, van Veghel-Plandsoen M, Boers R, et al.
Cancers (Basel)
. 2023 Sep;
15(18).
PMID: 37760576
Colorectal cancer (CRC) colonoscopic surveillance is effective but burdensome. Circulating tumor DNA (ctDNA) analysis has emerged as a promising, minimally invasive tool for disease detection and management. Here, we assessed...
6.
Bos M, Verhoeff S, Oosting S, Menke-van der Houven van Oordt W, Boers R, Boers J, et al.
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900167
According to the current guidelines, watchful waiting (WW) is a feasible option for patients with good or intermediate prognosis renal-cell carcinoma (RCC). However, some patients rapidly progress during WW, requiring...
7.
Deger T, Boers R, de Weerd V, Angus L, van der Put M, Boers J, et al.
Clin Epigenetics
. 2021 Oct;
13(1):196.
PMID: 34670587
Background: DNA methylation detection in liquid biopsies provides a highly promising and much needed means for real-time monitoring of disease load in advanced cancer patient care. Compared to the often-used...
8.
Adrianse R, Smith K, Gatbonton-Schwager T, Sripathy S, Lao U, Foss E, et al.
Epigenetics Chromatin
. 2018 Sep;
11(1):50.
PMID: 30170615
Background: The long noncoding RNA Xist is critical for initiation and establishment of X-chromosome inactivation during embryogenesis in mammals, but it is unclear whether its continued expression is required for...